tizanidine has been researched along with Daytime Sleepiness in 2 studies
tizanidine: RN given refers to parent cpd; structure
tizanidine : 2,1,3-Benzothiadiazole substituted at C-4 by a Delta(1)-imidazolin-2-ylamino group and at C-4 by a chloro group. It is an agonist at alpha2-adrenergic receptor sites.
Excerpt | Relevance | Reference |
---|---|---|
"Tizanidine HCl is an alpha2 adrenergic agonist indicated for treating spasticity due to MS or spinal cord injury." | 6.75 | Nightly sublingual tizanidine HCl in multiple sclerosis: clinical efficacy and safety. ( Auriel, E; Karni, A; Vakhapova, V, 2010) |
"Tizanidine HCl is an alpha2 adrenergic agonist indicated for treating spasticity due to MS or spinal cord injury." | 2.75 | Nightly sublingual tizanidine HCl in multiple sclerosis: clinical efficacy and safety. ( Auriel, E; Karni, A; Vakhapova, V, 2010) |
" Blood samples were collected to determine plasma tizanidine pharmacokinetic profiles, and computerized cognitive function tests were performed that yielded a validated composite score, Power of Attention, an index of sedation." | 2.72 | Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers. ( Henney, HR; Kovelesky, RA; Shah, J; Wesnes, KA, 2006) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Vakhapova, V | 1 |
Auriel, E | 1 |
Karni, A | 1 |
Shah, J | 1 |
Wesnes, KA | 1 |
Kovelesky, RA | 1 |
Henney, HR | 1 |
2 trials available for tizanidine and Daytime Sleepiness
Article | Year |
---|---|
Nightly sublingual tizanidine HCl in multiple sclerosis: clinical efficacy and safety.
Topics: Administration, Sublingual; Adrenergic alpha-2 Receptor Agonists; Adrenergic alpha-Agonists; Adult; | 2010 |
Effects of food on the single-dose pharmacokinetics/pharmacodynamics of tizanidine capsules and tablets in healthy volunteers.
Topics: Adolescent; Adult; Capsules; Clonidine; Cognition; Cross-Over Studies; Disorders of Excessive Somnol | 2006 |